Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Public ClinicalTrials.gov record NCT05207865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Open-label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
Study identification
- NCT ID
- NCT05207865
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 441 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2022 (Actual)
- Primary completion
- Jul 2, 2024 (Actual)
- Completion
- Jul 2, 2024 (Actual)
- Last update posted
- Sep 3, 2025
2022 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Elite Clinical Studies, LLC | Phoenix | Arizona | 85018 | — |
| Advanced Investigative Medicine, Inc. | Hawthorne | California | 90250 | — |
| Velocity Clinical Research - North Hollywood | North Hollywood | California | 91606 | — |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | — |
| Phoenix Medical Research, LLC | Miami | Florida | 33165 | — |
| The Headache Clinic | Alexandria | Louisiana | 71301 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| Michigan Head Pain & Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| CVS HealthHub - East Brunswick | East Brunswick | New Jersey | 08816 | — |
| CVS HealthHub - Lawrenceville | Lawrenceville | New Jersey | 08648 | — |
| CVS HealthHUB - Runnemede | Runnemede | New Jersey | 08078 | — |
| SPRI Clinical Trials, LLC | Brooklyn | New York | 11235 | — |
| Velocity Clinical Research | Cincinnati | Ohio | 45242 | — |
| OK Clinical Research, LLC | Edmond | Oklahoma | 73034 | — |
| Clinical Research Philadelphia, LLC | Philadelphia | Pennsylvania | 19114 | — |
| WR-ClinSearch, LLC | Chattanooga | Tennessee | 37421 | — |
| VIP Trails | San Antonio | Texas | 78230 | — |
| VIP Trials | San Antonio | Texas | 78230 | — |
| Tidewater Integrated Medical Research | Virginia Beach | Virginia | 23454 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05207865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05207865 live on ClinicalTrials.gov.